Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues:    
Product revenues $ 1,922,215 $ 1,366,153
Other service revenues 84,857 27,981
Total revenues 2,007,072 1,394,134
Cost of product revenues 752,464 696,546
Research and development costs 557,699 657,192
Selling, general, and administrative expenses 2,050,529 1,974,249
Operating loss (1,353,620) (1,933,853)
Other income (expense):    
Gain (loss) on change in fair value of derivative liabilities (93,046) 160,118
Other income, net 4,127 75,142
Interest expense, net (213,199) (345,225)
Net loss $ (1,655,738) $ (2,043,818)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.46) $ (0.89)
Weighted average shares outstanding:    
Basic and diluted (in shares) 3,622,032 2,291,147